Analyst sees CL in early stages of improved growth, balancin...

Analyst sees CL in early stages of improved growth, balancing contributions from various factors. Raymond James expects CL to drive sales higher with steady innovation, premiumization in Oral Care, and opportunity for increased category penetration for Hill's.